Skip to main content
. 2021 Mar 22;13(6):7828–7845. doi: 10.18632/aging.202858

Table 2. The rate of oxidative phosphorylation in SSM from young and aged mice with or without metformin treatment.

Mice 3 mo. 24 mo.
Groups Vehicle (n=13) Metformin (n=5) Vehicle (n=11) Metformin (n=5)
Complex I substrates: glutamate + malate
State 3 (nAO/min/mg) 291±16 326±7 220±14* 243±13
State 4 (nAO/min/mg) 44±4 48±3 37±2 41±2
RCR 6.9±0.4 7.1±0.5 6.1±0.3 6.1±0.6
2 mM ADP (nAO/min/mg) 345±16 377±6 251±21* 272±25
Complex II substrates: Succinate + rotenone
State 3 (nAO/min/mg) 642±25 587±24 557±20* 599±30
State 4 (nAO/min/mg) 179±8 172±8 149±5* 156±6
RCR 3.6±0.1 3.4±0.1 3.7±0.1 3.9±0.2
2 mM ADP (nAO/min/mg) 593±25 529±22 532±21 545±23

Mean ± SEM. *p<0.05 vs. 3 mo. Vehicle.